Alignment Healthcare (NASDAQ:ALHC) Insider Sells $902,729.03 in Stock

Key Points

• Alignment Healthcare insider Hyong Kim sold 51,379 shares for approximately $902,729, reducing their ownership by 12.42%.
• The company's stock recently traded at $17.19, down $0.36, with analysts having mixed ratings ranging from "Strong Buy" to "Sell."
• Alignment Healthcare reported quarterly earnings of $0.07 per share, outperforming expectations and showing a 49% revenue increase year-over-year.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Hyong Kim sold 51,379 shares of the firm's stock in a transaction that occurred on Thursday, October 9th. The shares were sold at an average price of $17.57, for a total transaction of $902,729.03. Following the completion of the transaction, the insider directly owned 362,333 shares of the company's stock, valued at $6,366,190.81. This represents a 12.42% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Hyong Kim also recently made the following trade(s):

• On Wednesday, October 8th, Hyong Kim sold 33,655 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.29, for a total transaction of $581,894.95.
• On Friday, August 22nd, Hyong Kim sold 24,800 shares of Alignment Healthcare stock. The shares were sold at an average price of $16.00, for a total transaction of $396,800.00.
• On Monday, August 11th, Hyong Kim sold 18,600 shares of Alignment Healthcare stock. The shares were sold at an average price of $14.54, for a total transaction of $270,444.00.

Alignment Healthcare Stock Performance

Shares of Alignment Healthcare stock traded down $0.36 on Friday, reaching $17.19. 432,343 shares of the stock were exchanged, compared to its average volume of 3,166,579. The firm has a market capitalization of $3.40 billion, a PE ratio of -61.58 and a beta of 1.18. Alignment Healthcare, Inc. has a 1-year low of $10.11 and a 1-year high of $21.06. The business has a fifty day moving average price of $15.97 and a two-hundred day moving average price of $15.67. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $960.25 million. During the same quarter in the prior year, the firm posted ($0.13) earnings per share. The company's quarterly revenue was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Alignment Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in ALHC. Voya Investment Management LLC lifted its holdings in shares of Alignment Healthcare by 61.0% during the third quarter. Voya Investment Management LLC now owns 3,196,297 shares of the company's stock worth $55,775,000 after buying an additional 1,210,930 shares in the last quarter. State of Wyoming lifted its stake in Alignment Healthcare by 133.9% in the second quarter. State of Wyoming now owns 20,406 shares of the company's stock valued at $286,000 after buying an additional 11,683 shares during the period. Caxton Associates LLP acquired a new position in shares of Alignment Healthcare during the second quarter worth approximately $240,000. Tower Research Capital LLC TRC raised its position in shares of Alignment Healthcare by 2,098.8% during the second quarter. Tower Research Capital LLC TRC now owns 19,679 shares of the company's stock worth $276,000 after purchasing an additional 18,784 shares during the period. Finally, Tidal Investments LLC grew its holdings in Alignment Healthcare by 4.9% during the second quarter. Tidal Investments LLC now owns 18,094 shares of the company's stock worth $253,000 after buying an additional 852 shares in the last quarter. 86.19% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on ALHC shares. Wall Street Zen cut shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. Zacks Research raised shares of Alignment Healthcare from a "hold" rating to a "strong-buy" rating in a research report on Monday, September 29th. KeyCorp upgraded shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price for the company in a research note on Monday, August 25th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Alignment Healthcare in a research note on Wednesday. Finally, Barclays upgraded shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and boosted their price objective for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $18.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.